Radiosynovectomy: Current status in the management of arthritic conditions

Nuclear Medicine Communications

Volumn 29, Issue 9, 2008, Pages 755-758

  Uğur, Ömer ^a   Gedik, Gonca Kara ^a   Atilla, Bülent ^a   Rubello, Domenico ^a  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOPHARMACEUTICAL AGENT; DYSPROSIUM; ERBIUM 169; GOLD 198; HOLMIUM; PHOSPHORUS 32; RHENIUM 186; RHODIUM; SAMARIUM 153; TRIAMCINOLONE; YTTRIUM SILICATE Y 90;

ARTHRITIS; ARTHROPATHY; CLINICAL TRIAL; EDITORIAL; HUMAN; INFLAMMATION; METABOLISM; PIGMENTED VILLONODULAR SYNOVITIS; SYNOVIAL FLUID; SYNOVITIS; BETA RADIATION; CHROMOSOME ABERRATION; DRUG MECHANISM; DRUG SAFETY; HEMARTHROSIS; HEMOPHILIA; RADIOISOTOPE THERAPY; RADIOSYNOVECTOMY; RADIOSYNOVIORTHESIS; RHEUMATOID ARTHRITIS;

ARTHRITIS; CLINICAL TRIALS AS TOPIC; HUMANS; INFLAMMATION; JOINT DISEASES; RADIOPHARMACEUTICALS; SYNOVIAL FLUID; SYNOVITIS; SYNOVITIS, PIGMENTED VILLONODULAR;

EID: 53149123301     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283023f9e     Document Type: Editorial

References (31)

1. Schneider P, Farahati J, Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 2005; 46:48S-54S.
2. Harbert JC. Radionuclide therapy in joint diseases. In: Harbert JC, editor. Nuclear medicine diagnosis and therapy. New York: Thieme Medical Publishers, Inc.; 1996. pp. 1093-1110.
3. Fellinger K, Schmid J. Die Lokale Behandlung der rheumatischen Erkrankungen (Local therapy of rheumatic diseases). Wien Z Inn Med 1952; 33:351-363.
4. 198Au) in the treatment of persistent knee-effusions. Ann Rheum Dis 1963; 22:435-439.
5. Clunie G, Fisher M. EANM procedure guidelines for radiosynovectomy. Eur J Nucl Med 2003; 30:BP12-BP16.
6. Siegel ME, Siegel HJ, Luck JV. Radiosynovectmy’s clinical applications and cost effectiveness: a review. Semin in Nucl Med 1997; 27:364-371.
7. Deutsch E, Brodack JW, Deutsch KF. Radiation synovectomy revisited. Eur J Nucl Med 1993; 20:1113-1127.
8. Bridgman JF, Bruckner F, Bleehan NM. Radioactive yttrium in the treatment of rheumatoid knee effusions. Ann Rheum Dis 1971; 30:180-182.
9. Grant EN, Bellamy N, Fryday-Field K, Dinsey T, Driedger A, Hobby K, et al. Double-blind randomized controlled trial and six-year open follow up of ytttium-90 radiosynovectomy versus triamcinolone hexacetonide in persistent rheumatoid knee synovitis. Inflammopharmacology 1992; 1:231-238.
10. O’Duffy EK, Clunie GPR, Lui D, Edwards JC, Ell PJ. Double blind glucocorticoid controlled trial of samarium-153 particulate hydroxyapatite radiation synovectomy for chronic knee synovitis. Ann Rheum Dis 1999; 58:554-558.
11. Das BK, Pradhan PK, Shukla AK, Misra R. Role of radiosynovectomy in rheumatoid arthritis. J Indian Rheumatol Assoc 2004; 12:98-103.
12. 32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis. Haemophilia 2001; 7:40-49.
13. Siegel HJ, Luck JV, Siegel ME, Quiness C, Anderson E. Hemarthrosis and synovitis associated with hemophilia: clinical use of P-32 chromic phosphate synoviorthesis for treatment. Radiology 1994; 190:257-261.
14. Siegel ME, Siegel HJ. Radionuclide synoevctomy. In: Henkin RE, Bova D, Dillehay GL, Halam JR, Karesh SM, Wagner RH, Zimmer AM, editors. Nuclear medicine. 2nd ed. Pennsylvania: Mosby Elsevier; 2006. pp. 1597-1603.
15. Dunn AL, Busch MT, Wyly JB, Abshire TC. Radionuclide synovectomy for hemophilic arthropathy: a comprehensive review of safety and efficacy and recommendation for a standardized treatment protocol. Thromb Haemost 2002; 87:383-393.
16. Dunn AL, Manco-Johnson M, Busch MT, Balark KL, Abshire TC. Leukemia and P32 radionuclide synovectomy for hemophilic arthropathy. J Thromb Haemost 2005; 3:1541.
17. National Hemophilia Foundation Home Page. 14 October 2006, MASAC recommendation number 176, 〈http://www.hemophilia.org〉 (16 March 2008).
18. Gedik GK, Ugur O, Atilla B, Pekmezci M, Yildirim M, Seven B, et al. Comparison of extrarticular leakage values of radiopharmaceuticals used for radionuclide synovectomy. Ann Nucl Med 2006; 20:183-188.
19. Kavakli K, Aydogdu S, Omay SB, Duman Y, Taner M, Capaci K, et al. Long-term evaluation of radioisotope synovectomy with Yttrium 90 for chronic synovitis in Turkish haemophiliacs: Izmir experience. Haemophilia 2006; 12:28-35.
20. Wiss DA. Recurrent villonodular synovitis of the knee: successful treatment with yttrium-90. Clin Orthop 1982; 169:139-144.
21. Doherty M, Dieppe PA. Effect of intra-articular yttrium-90 on chronic pyrophosphate of the knee. Lancet 1981; 2:1243-1246.
22. Will R, Laing B, Edelman J, Lovegrove F, Surveyor I. Comparison of two yttrium-90 regimens in inflammatory and ostoarthropathies. Ann Rheum Dis 1992; 51:262-265.
23. Kröger S, Sawula JA, Klutmann S, Brenner W, Bohuslavizki KH, Henze E, et al. Efficacy of radiation synovectomy in degenerative inflammatory and chronic inflammatory joint diseases. Nuklearmedizin 1999; 38:279-284.
24. Gedik GK, Ugur O, Atilla B, Dundar S. Is corticosteroid coinjection necessary for radiosynoviorthesis of patients with hemophila. Clin Nucl Med 2004; 29:538-541.
25. Chinol M, Vallabhajosula G, Goldsmith SJ, Klein MJ, Deutsch KF, Chinen LK, et al. Chemistry and biological behavior of samarium-153 and rhenium-186-labeled hydoxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 1993; 34:1536-1542.
26. Edmonds J, Smart R, Laurent R, Butler P, Brooks P, Hoschl R, et al. A comparative study of the safety and efficacy of dysprosium-165 hydroxide-macroaggregate and yttrium-90 silicate colloid in radiation synovectomy - a multicenter double blid clinical trial. Australian Dysprosium Trial Group. Br J Rheumatol 1994; 33:947-953.
27. Song J, Suh CH, Park YB, Lee SH, Yoo NC, Lee JD, et al. A phase I/IIa study on intra-articular injection of holmium-166-chitosan complex for the treatment of knee synovitis of rheumatoid arthritis. Eur J Nucl Med 2001; 28:489-497.
28. 188Re radiopharmaceuticals for radiosynovectomy: evaluation and comparison of tin colloid, hydroxyapatite and tin-ferric hydroxide macroaggregates. BMC Nucl Med 2004; 4:1.
29. Chattopadhyay S, Viamlnanth KV, Saha S, Korde A, Sarma HD, Pal S, et al. Preparation and evaluation of a new radiopharmaceutical for radiosynovectomy, (111)Ag-labelled hyrdoxyapatite(HA) particles. Appl Radiat Isot 2008; 66:334-339.
30. Rivard GE, Girard M, Bélanger R, Jutras M, Guay JP, Marton D. Synoviorthesis with colloidal P32 chromic phosphate for the treatment of hemophilic arthropathy. J Bone Joint Surg Am 1994; 76:482-488.
31. Turkmen C, Ozturk S, Unal SN, Zulfikar B, Taser O, Sanli Y, et al. The genotoxic effects in lymphocyte cultures of children treated with radiosynovectomy by using yttrium-90 citrate colloid. Cancer Biotherm Radiopharm 2007; 22:393-399.